Disease · MONDO_0010811
Comparisons in its trials25
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 25
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Vibegron 75 Milligrams (mg) Once Daily (QD) vs Placebo: deaths from any cause | 0 of 553 | 0 of 551 | 1,104 | NCT03902080 | Trial comparisons |
| Vibegron 75 Milligrams (mg) Once Daily (QD) vs Placebo: serious adverse events | 24 of 553 | 16 of 551 | 1,104 | NCT03902080 | Trial comparisons |
| Tadalafil vs Placebo: serious adverse events | 2 of 306 | 1 of 304 | 610 | NCT01460342 | Trial comparisons |
| Placebo + Tam 0.2mg vs Dut 0.5 mg + Tam 0.2 mg: deaths from any cause | 1 of 302 | 2 of 305 | 607 | NCT02058368 | Trial comparisons |
| Placebo + Tam 0.2mg vs Dut 0.5 mg + Tam 0.2 mg: serious adverse events | 52 of 302 | 49 of 305 | 607 | NCT02058368 | Trial comparisons |
| Silodosin vs Placebo: serious adverse events | 3 of 233 | 4 of 229 | 462 | NCT00224120 | Trial comparisons |
| Silodosin vs Placebo: serious adverse events | 3 of 233 | 3 of 228 | 461 | NCT00224107 | Trial comparisons |
| Dutasteride vs Placebo: serious adverse events | 20 of 193 | 8 of 184 | 377 | NCT00368979 | Trial comparisons |
| Saw Palmetto vs Placebo: serious adverse events | 18 of 176 | 17 of 181 | 357 | NCT00603304 | Trial comparisons |
| Tadalafil vs Placebo: serious adverse events | 0 of 167 | 0 of 161 | 328 | NCT02431754 | Trial comparisons |
| Tadalafil vs Placebo: serious adverse events | 2 of 161 | 0 of 164 | 325 | NCT00827242 | Trial comparisons |
| Tadalafil vs Placebo: serious adverse events | 2 of 158 | 3 of 160 | 318 | NCT00848081 | Trial comparisons |
| Tadalafil vs Placebo: Number of Men With Treatment-emergent Dizziness | 11 of 158 | 9 of 159 | 317 | NCT00848081 | Trial comparisons |
| Botulinum Toxin Type A vs Placebo (Normal Saline): serious adverse events | 5 of 158 | 8 of 157 | 315 | NCT01107392 | Trial comparisons |
| Dutasteride 0.5 mg vs Placebo: serious adverse events | 0 of 126 | 1 of 127 | 253 | NCT00527605 | Trial comparisons |
| 100 Units Botulinum Toxin Type A vs 300 Units Botulinum Toxin Type A: serious adverse events | 7 of 68 | 5 of 66 | 134 | NCT00451191 | Trial comparisons |
| Study Group vs Control Group: serious adverse events | 0 of 64 | 0 of 58 | 122 | NCT01678313 | Trial comparisons |
| 100 Units Botulinum Toxin Type A vs 300 Units Botulinum Toxin Type A: Improvement in the AUA Symptom Score Index by 30% From Baseline Within the First 12 Weeks After Injection. | 46 of 53 | 50 of 55 | 108 | NCT00451191 | Trial comparisons |
| Tadalafil vs Placebo: serious adverse events | 0 of 47 | 2 of 50 | 97 | NCT01152190 | Trial comparisons |
| PRX302 vs Placebo: serious adverse events | 1 of 61 | 0 of 31 | 92 | NCT00889707 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0010811/comparisons